Researchers sought to determine the long-term adverse events that occur as a result of pediatric ALL.
Researchers sought to determine whether daratumumab with lenalidomide and dexamethasone would improve survival in patients with newly diagnosed multiple myeloma.
Researchers sought to determine whether combination therapy with indatuximab ravtansine would have clinical activity in patients with relapsed/refractory multiple myeloma.
Researchers sought to determine the effect of CEBPA-bZip mutations on disease prognosis for patients with acute myeloid leukemia.
Researchers sought to determine whether acalabrutinib, venetoclax, and obinutuzumab would be a helpful option for frontline treatment of CLL.
Researchers sought to determine whether salvage therapy with high-dose chemotherapy followed by ASCT would improve survival in patients with MM.
Researchers sought to determine whether patients with B-NHL who had treatment with anti-CD20 antibodies had an impaired serological response to an mRNA COVID-19 vaccine.
Researchers sought to determine whether patients with B-ALL who progress after CAR-T therapy would have a poor prognosis.
Researchers sought to determine whether therapy with carfilzomib, lenalidomide, and dexamethasone would be effective for patients with newly diagnosed multiple myeloma.
Researchers sought to determine whether patients with lymphoma would develop antibodies with a COVID-19 vaccine 6 months after treatment with anti-CD20-containing therapy.
